Back to Search
Start Over
Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL pro substrate degradome.
- Source :
-
Cell reports [Cell Rep] 2021 Oct 26; Vol. 37 (4), pp. 109892. Date of Electronic Publication: 2021 Oct 09. - Publication Year :
- 2021
-
Abstract
- The main viral protease (3CL <superscript>pro</superscript> ) is indispensable for SARS-CoV-2 replication. We delineate the human protein substrate landscape of 3CL <superscript>pro</superscript> by TAILS substrate-targeted N-terminomics. We identify more than 100 substrates in human lung and kidney cells supported by analyses of SARS-CoV-2-infected cells. Enzyme kinetics and molecular docking simulations of 3CL <superscript>pro</superscript> engaging substrates reveal how noncanonical cleavage sites, which diverge from SARS-CoV, guide substrate specificity. Cleaving the interactors of essential effector proteins, effectively stranding them from their binding partners, amplifies the consequences of proteolysis. We show that 3CL <superscript>pro</superscript> targets the Hippo pathway, including inactivation of MAP4K5, and key effectors of transcription, mRNA processing, and translation. We demonstrate that Spike glycoprotein directly binds galectin-8, with galectin-8 cleavage disengaging CALCOCO2/NDP52 to decouple antiviral-autophagy. Indeed, in post-mortem COVID-19 lung samples, NDP52 rarely colocalizes with galectin-8, unlike in healthy lungs. The 3CL <superscript>pro</superscript> substrate degradome establishes a foundational substrate atlas to accelerate exploration of SARS-CoV-2 pathology and drug design.<br />Competing Interests: Declaration of interests The authors declare no competing interests.<br /> (Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 2211-1247
- Volume :
- 37
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Cell reports
- Publication Type :
- Academic Journal
- Accession number :
- 34672947
- Full Text :
- https://doi.org/10.1016/j.celrep.2021.109892